Greg Meadows Overview

  • Investor Type
  • Angel
  • Investments
  • 1
  • Portfolio
  • 1

Greg Meadows General Information


Mr. Greg Meadows serves as Chief Executive Officer at United Skin Specialists. Mr. Greg Meadows served as Chief Executive Officer at Rocky Mountain Urgent Care. Greg has over two decades of healthcare experience in progressive leadership roles within multiple healthcare service companies. As CEO of Rocky Mountain Healthcare Companies, Greg is responsible for ensuring the organization creates great patient and employee experiences as well as great healthcare outcomes to drive profitable growth and expansion in the Denver Metro Area. Greg most recently served as the President of Home Solutions and was responsible for leading sales, operations, customer service, and managed care for the rapidly-growing home infusion company. During his tenure at Home Solutions, the company began a profitable growth trajectory that exceeded 20% YoY for its core therapy and new patient admits, which drove significant profit increases as well as patient and referral source satisfaction. Greg departed Home Solutions after its completed sale to BioScrip (Nasdaq: BIOS), a national specialty pharmacy provider. Prior to Home Solutions, Greg served as the President and Chief Executive Officer for Multispecialty Physician Partners, a subsidiary of Renal Ventures Management. Prior to joining Multispecialty Physician Partners, Greg served as the President of CoramRx Specialty Pharmacy and as the Executive Vice President of Managed Markets, Contracts and Pricing, and Financial Analysis at Coram Specialty Infusion Services. During Greg's tenure with CoramRx the company experienced double-digit compounded annual growth and outperformed the specialty pharmacy market profit margin by five times. While serving on their executive leadership team, Coram Specialty Infusion Services became one of the top-performing healthcare companies in the U.S., with a double-digit compounded annual growth rate and an EBITDA increase of more than 250%. Coram Specialty Infusion Services subsequently sold to CVS Pharmacy, a subsidiary of CVS Health (NYSE: CVS). Greg brings a depth of relevant experience from senior leadership positions in the healthcare industry. Prior to his years at Coram, he spent 13 years with Schering-Plough, now Merck (NYSE: MRK), in several areas including sales leadership, managed care, government affairs, pricing, and marketing. Mr. Meadows' career began as a political lobbyist for the healthcare and insurance industries in the early 1990s. Greg earned a Bachelor of Arts, and a Master of Public Administration from Louisiana State University.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 2 Carlson Parkway North
  • Suite 240
  • Plymouth, MN 55447
  • United States
+1 (844) 000-0000

Greg Meadows Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000000 25-Oct-2018 0000 00000 00000 Clinics/Outpatient Services Generating Revenue 0000 0000000
To view Greg Meadows’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Greg Meadows Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Greg Meadows Team (1)

Name Title Deals Funds Boards Office
Greg Meadows Angel Investor 0 Plymouth, MN
To view Greg Meadows’s complete team members history, request access »